To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults | MicrobiomeTrials← Back to trialsNCT05805826
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2023-03-23Est. Completion: 2031-06-19
Enrollment target: 936 participants Locations- HOPE Research Institute, Phoenix, Arizona, United States
- Anaheim Clinical Trials, LLC, Anaheim, California, United States
- Alliance for Multispecialty Research, LLC, Doral, Florida, United States
- Indago Research & Health Center, Inc, Hialeah, Florida, United States
- Research Centers of America, Hollywood, Florida, United States
- Miami Clinical Research, Miami, Florida, United States
- New Horizon Research Center, Miami, Florida, United States
- Charisma Medical and Research Center, Miami Lakes, Florida, United States
- Private Practice - Dr. Hector Fabregas, Pembroke Pines, Florida, United States
- DBC Research USA, Pembroke Pines, Florida, United States
- BRCR Medical Center Inc., Plantation, Florida, United States
- Clinical Research Trials of Florida, Tampa, Florida, United States
- Great Lakes Clinical Trials - Ravenswood, Chicago, Illinois, United States
- Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States
- Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Washington University, St Louis, Missouri, United States
- NYU Langone Health, New York, New York, United States
- Rochester Clinical Research, Inc., Rochester, New York, United States
- Qcare Site Services Inc. d/b/a Avacare, Durham, North Carolina, United States
- CTI Clinical Research Center, Cincinnati, Ohio, United States
- Benchmark Research, Austin, Texas, United States
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Tomball, Texas, United States
Other microbiome trials you might be interested in
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
Re-exposure to systemic antibiotics (i.e., antibiotics absorbed into the bloodstream) is common after a Clostridioides d…
Montreal, CanadaEst. completion Oct 1, 2028